SIGA Technologies, Inc. (NASDAQ:SIGA) Commences Chapter 11 Case To Assure Its Commitment To Supply Antiviral Smallpox Drug

Boston, MA 09/17/2014 (wallstreetpr) – Pharmaceutical company, SIGA Technologies, Inc. (NASDAQ:SIGA) disclosed that it has preferred the route of Chapter 11 bankruptcy protection to not only preserve itself, but also assure its capability to satisfy its commitment to supply antiviral smallpox drug, Tecovirimat. Bankruptcy Protection The company said that it has voluntarily filed a petition […]

PharmAthene, inc. (NYSEMKT:PIP) Se to Earn $500Million from a Smallpox Drug

Boston, MA 08/12/2014 (wallstreetpr) – Biodefense Company, PharmAthene, inc. (NYSEMKT:PIP), may earn up to $500 million from a dispute involving SIGA Technologies, Inc. (NASDAQ:SIGA) on a smallpox drug; this is after a judge ruled on the same. Siga may be forced to pay up to $500 million in the form of lost profits under a […]